Pfizer's Competitors, Revenue, Number of Employees, Funding and Acquisitions

Pfizer is a pharmaceutical company that develops and produces medicines and vaccines for the healthcare industry.

Pfizer ...
Read more

Based on data from Pfizer's latest SEC filings

Annual Revenue

Based on data from Pfizer's latest SEC filings

Employees

Albert Bourla's photo - CEO of Pfizer

CEO

Albert Bourla

CEO Approval Rating

60/100

OVERVIEW

Founded:

1849

Headquarters:

New YorkNew York

Status:

PublicIndependent Company of NYSEPFE

Industry Sector:

Pharmaceuticals

Biotechnology

SIC Code:

Top Competitors or Alternatives

Missing a competitor? Contribute!

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Abbott a competitor of Pfizer?

Want more news like this in your inbox? Get access for free

Competitive Analysis

TOP COMPETITORS OR ALTERNATIVES

Merck is the top competitor of Pfizer. Merck is headquartered in Kenilworth, New Jersey, and was founded in 1891. Merck competes in the Pharmaceuticals field. Merck generates 82% the revenue of Pfizer.

Novartis is perceived as one of Pfizer's biggest rivals. Novartis was founded in Basel, Basel-City} in 1996. Like Pfizer, Novartis also operates in the Pharmaceuticals industry. Compared to Pfizer, Novartis generates $3.3B less revenue.

Bristol Myers Squibb is seen as one of Pfizer's top competitors. Bristol Myers Squibb is a Public company that was founded in New York, New York in 1858. Like Pfizer, Bristol Myers Squibb also works within the Pharmaceuticals industry. Bristol Myers Squibb has 69,500 fewer employees vs. Pfizer.

RANK

COMPANY

LEADERSHIP

CEO SCORE

EMPLOYEES

TOTAL FUNDING

REVENUE

Albert Bourla

CEO

- -
92,400
$0
$53.7B
1

Kenneth C. Frazier

Chairman & CEO

59/100
69,000
- -
$44.4B
2

Vasant Narasimhan

CEO

81/100
118,393
- -
$50.3B
3

Giovanni Caforio

Chairman & CEO

74/100
23,300
- -
$23.9B
4

Alex Gorsky

Chairman & CEO

66/100
135,100
- -
$81.3B
5

Emma Walmsley

CEO

71/100
99,827
- -
$39.4B
6

Miles D. White

Chairman & CEO

58/100
103,000
$6.9M
$30.9B
7

Umang Vohra

CEO

70/100
12,235
- -
$1.9B
8

Severin Schwan

CEO

54/100
94,052
- -
$932.5M
9

David A. Ricks

Chairman & CEO

67/100
38,680
- -
$24.7B
10

Werner Baumann

Chairman & CEO

59/100
116,998
- -
$53.6B

Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$53.7B

Pfizer's revenue is the ranked 2nd among it's top 10 competitors. The top 10 competitors average 36.8B. Over the last four quarters, Pfizer's revenue has decreased by $-34000000. Specifically, in Q2 2019's revenue was $13.3B; in Q1 2019, it was $13.1B; in Q4 2018, it was $14B; in Q3 2018, Pfizer's revenue was $13.3B.

Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Array BioPharma Inc.

Jun 2019

Source »
$11.4B
Array is a biopharmaceutical company that researches, develops and commercializes targeted small molecule medicines to treat cancer.
Therachon AG

May 2019

Source »
$340M
Therachon develops protein therapeutics for the treatment of achondroplasia.
Bamboo Therapeutics

Aug 2016

Source »
$645M
Bamboo Therapeutics researches, discovers, develops, produces and commercialises gene therapies for the treatment of neurological diseases.
Medivation, Inc.

Aug 2016

Source »
$14B
Medivation is engaged in development and commercialization of novel small molecule drugs to treat serious diseases.
Anacor Pharmaceuticals, Inc.

May 2016

Source »
$5.2B
Anacor discovers, develops and commercializes novel small-molecule therapeutics for the treatment of fungal, bacterial and inflammatory diseases.

These are all the companies that Pfizer has acquired. Pfizer has acquired 13 companies and its latest acquisition was Array BioPharma Inc. in Jun 2019. Array is a biopharmaceutical company that researches, develops and commercializes targeted small molecule medicines to treat cancer.

Investments

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

SpringWorks develops and commercializes clinical drug therapies for the treatment of cancer, oncology and rare genetic diseases.
$125M
Mar 31, 2019
Series B
Sep 13, 2019
Vivet Therapeutics is a biotech company that develops and commercializes gene therapies for the treatment of liver disorders and orphan diseases.
$51.1M
Mar 19, 2019
Equity
-
NextCure is a biopharmaceutical company that researches and develops immuno-medicines for the treatment of cancer.
$93.4M
Nov 12, 2018
Series B
-
iTeos focuses on discovering and developing immune-oncology therapeutics to treat inflamed and non-inflamed tumors.
$75M
Jun 19, 2018
Series B
-
BioMarin is a biotechnology company that develops and commercializes therapeutics for the treatment of genetic diseases.
$20M
Jun 06, 2018
Debt
Jul 22, 1999

These are all the companies that Pfizer has invested in. Pfizer has invested 13 companies and its latest investment was Array BioPharma Inc. in Jun 2019. Array is a biopharmaceutical company that researches, develops and commercializes targeted small molecule medicines to treat cancer.

Pfizer News

October 15, 2019BioPortfolio

Pfizer launches catfish counterfeit medicines campaign

The campaign is aimed at students who don't know what they could be buying online.... See more »
October 15, 2019FiercePharma

Can Pfizer's abrocitinib really challenge Dupixent? Side effects could get in the way, analyst says

Pfizer put up some impressive data for its would-be rival to Regeneron and Sanofi's Dupixent in atopi... See more »
October 14, 2019BioPortfolio

Pfizer Announces Eczema Drug Abrocitinib Passed 2nd Phase III Trial httpdlvr.itRGBKXNÂpic.twitter.comLybRXQo39J

Pfizer Announces Eczema Drug Abrocitinib Passed 2nd Phase III Trial httpdlvr.itRGBKXN pic.twitter.com... See more »
October 14, 2019BioPortfolio

Pfizer reveals strong Phase 3 data for abrocitinib in AtopicDermatitis httpbit.ly2BavBrRÂ pharmapic.twitter.comiJqJk7lRyr

Pfizer reveals strong Phase 3 data for abrocitinib in AtopicDermatitis httpbit.ly2BavBrR pharma pic.t... See more »
October 14, 2019Zacks

Novartis, J&J, Pfizer, Novo Nordisk and Glaxo

The Zacks Analyst Blog Highlights: Novartis, J&J, Pfizer, Novo Nordisk and Glaxo... See more »
October 14, 2019PharmaLive

Success and a successor

After a 2018 in which Pfizer reorganized the company's businesses and built on its foundation for fut... See more »
October 13, 2019Business Medical Dialogues

Pfizer, Akcea enter licensing agreement for investigational antisense therapy AKCEA-ANGPTL3-LRx

New Delhi: Pfizer Inc. and Akcea Therapeutics, Inc., a majority-owned affiliate of Ionis Pharmaceutic... See more »

Pfizer Blogs

May 28, 2014Pfizer Blog

Entry into Indonesia – Providing Innovative Solutions to Quality Care

Being in a completely new country, it’s easy to forget that sometimes even simple, routine tasks aren... See more »

Pfizer Press Releases

August 7, 2019WebWire

Pfizer Announces Phase 3 Top-Line Results for Rivipansel in Patients with Sickle Cell Disease Experiencing a Vaso-Occlusive Crisis

Pfizer Inc. (NYSE:PFE) announced that the Phase 3� R ivipansel (GMI-1070):� E valuating� S afet... See more »
July 31, 2019PR Newswire

Former Pfizer Chief Human Resources Officer Chuck Hill Joins Custodia Financial Strategic Advisory Council

DALLAS, July 31, 2019 /PRNewswire/ -- Custodia Financial, the creator of Retirement Loan Eraser (RLE)... See more »
July 2, 2019StreetInsider

AskBio's Perspective on Pfizer's 1b Clinical Trial Results on Duchenne MD Gene Therapy

Pfizer reported results from a Phase 1b clinical trial of PF-06939926, its investigational gene thera... See more »
July 2, 2019PRWeb

AskBio's Perspective on Pfizer's 1b Clinical Trial Results on Duchenne MD Gene Therapy

On the forefront of the gene therapy industry, AskBio celebrates the accomplishments of all companies... See more »
June 17, 2019GlobalNewswire

Rigrodsky & Long, P.A. Announces Investigation Of Buyout

WILMINGTON, Del., June 17, 2019 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A.:... See more »
April 16, 2019EIN Presswire

Aspect Furniture supply Pfizer with Office Furniture for Sydney office fitout

Pfizer Australia, one of the world's leading biopharmaceutical companies, has relocated its Australia... See more »

Pfizer Videos

Social Statistics

Headquarters

235 East 42nd Street

New York, New York10017

1-212-733-2323

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Pfizer (NYSE: PFE) is a pharmaceutical firm that develops and produces medicines and vaccines for healthcare industries. As a research-based, global pharmaceutical company, it discovers, develops, manufactures, and markets medicines for humans and ani...

CEO

Pfizer's CEO, Albert Bourla, currently has an approval rating of 60%. Pfizer's primary competitors are Merck, Novartis & Bristol Myers Squibb.

Website

pfizer.com

Frequently Asked Questions about Pfizer

  1. When was Pfizer founded?

    Pfizer was founded in 1849
  2. Who is Pfizer's CEO?

    Pfizer's CEO is Albert Bourla
  3. How much revenue does Pfizer generate?

    Pfizer generates $53.7B in revenue
  4. How much funding does Pfizer have?

    Pfizer has historically raised $0 in funding
  5. Where is Pfizer's headquarters?

    Pfizer's headquarters is in New York New York, USA
  1. How many employees does Pfizer have?

    Pfizer has 92,400 employees
  2. What sector does Pfizer operate in?

    Pfizer is in Pharmaceuticals, Biotechnology
  3. Who are Pfizer's competitors?

    Pfizer's top competitors are Merck, Novartis, Bristol Myers Squibb
  4. Who has Pfizer invested in?

    Pfizer's has invested in companies such as SpringWorks, Vivet Therapeutics, NextCure